BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24343405)

  • 1. ACP Journal Club. Review: Combined oral contraceptives are associated with venous thrombosis.
    Harper DM; Wilfling LE; Blanner CF
    Ann Intern Med; 2013 Dec; 159(12):JC12. PubMed ID: 24343405
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of venous thrombosis varies with different types of combined oral contraceptives.
    DeSancho MT
    Evid Based Med; 2014 Apr; 19(2):e11. PubMed ID: 24288174
    [No Abstract]   [Full Text] [Related]  

  • 3. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
    Stegeman BH; de Bastos M; Rosendaal FR; van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    BMJ; 2013 Sep; 347():f5298. PubMed ID: 24030561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone-binding globulin levels in premenopausal women.
    Stegeman BH; Raps M; Helmerhorst FM; Vos HL; van Vliet HA; Rosendaal FR; van Hylckama Vlieg A
    J Thromb Haemost; 2013 Jan; 11(1):203-5. PubMed ID: 23122048
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
    Spitzer WO
    J Obstet Gynaecol Can; 2004 Jun; 26(6):549-50. PubMed ID: 15762006
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dose contraceptive formulations: is further reduction in steroid dosage justified?
    Elstein M
    Adv Contracept; 1994 Mar; 10(1):1-4. PubMed ID: 8030448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P; Vekemans M
    Rev Med Brux; 1987 Nov; 8(9):440-6. PubMed ID: 3423522
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives according to the normophasic principle.
    Borglin NE; Klottrup P
    Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misleading advertising.
    Bridge DT
    Med J Aust; 1987 Feb; 146(4):229-30. PubMed ID: 3574223
    [No Abstract]   [Full Text] [Related]  

  • 12. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
    Kluft C
    Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clarification concerning NuvaRing].
    Jonsson M
    Lakartidningen; 2007 Jan 31-Feb 6; 104(5):355. PubMed ID: 17328363
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in alpha 1-antitrypsin (AAT) and alpha 2-macroglobulin serum concentrations during treatment with oral estro-progestogens.
    Paternoster D; Maggino T; Valente S; Pengo V; Ongaro G
    Quad Sclavo Diagn; 1982 Jun; 18(2):132-9. PubMed ID: 6188185
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives.
    Alsina JC
    Eur J Contracept Reprod Health Care; 2010 Feb; 15(1):1-3. PubMed ID: 20136565
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast cancer.
    Edgren RA
    Fertil Steril; 1992 Dec; 58(6):1271-2. PubMed ID: 1459288
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic impact of combined hormonal contraceptives containing estradiol.
    Grandi G; Napolitano A; Cagnacci A
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):779-87. PubMed ID: 27187588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.